Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
+0.105 (2.59%)
Jul 19, 2024, 4:30 PM EDT - Market closed

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $125.52 million. The enterprise value is $41.91 million.

Market Cap 125.52M
Enterprise Value 41.91M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

RLMD has 30.17 million shares outstanding. The number of shares has increased by 0.11% in one year.

Shares Outstanding 30.17M
Shares Change (YoY) +0.11%
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 8.04%
Owned by Institutions (%) 49.22%
Float 27.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.74
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.83, with zero debt.

Current Ratio 6.83
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -102.10% and return on invested capital (ROIC) is -136.77%.

Return on Equity (ROE) -102.10%
Return on Assets (ROA) -91.30%
Return on Capital (ROIC) -136.77%
Revenue Per Employee n/a
Profits Per Employee -$4.71M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +51.27% in the last 52 weeks. The beta is 0.50, so RLMD's price volatility has been lower than the market average.

Beta (5Y) 0.50
52-Week Price Change +51.27%
50-Day Moving Average 3.30
200-Day Moving Average 3.79
Relative Strength Index (RSI) 66.95
Average Volume (20 Days) 119,771

Short Selling Information

The latest short interest is 1.01 million, so 3.36% of the outstanding shares have been sold short.

Short Interest 1.01M
Short Previous Month 1.55M
Short % of Shares Out 3.36%
Short % of Float 3.65%
Short Ratio (days to cover) 11.62

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -98.54M
Pretax Income -94.30M
Net Income -94.30M
EBITDA -94.30M
EBIT -94.30M
Earnings Per Share (EPS) -$3.12
Full Income Statement

Balance Sheet

The company has $83.61 million in cash and no debt, giving a net cash position of $83.61 million or $2.77 per share.

Cash & Cash Equivalents 83.61M
Total Debt n/a
Net Cash 83.61M
Net Cash Per Share $2.77
Equity (Book Value) 72.05M
Book Value Per Share 2.39
Working Capital 72.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow -48.19M
Capital Expenditures n/a
Free Cash Flow -48.19M
FCF Per Share -$1.60
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.11%
Shareholder Yield -0.11%
Earnings Yield -75.12%
FCF Yield -38.39%

Analyst Forecast

The average price target for RLMD is $2.00, which is -51.92% lower than the current price. The consensus rating is "Strong Sell".

Price Target $2.00
Price Target Difference -51.92%
Analyst Consensus Strong Sell
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.

Last Split Date Sep 30, 2019
Split Type Reverse
Split Ratio 1:4


Altman Z-Score n/a
Piotroski F-Score 1